← Evidence map

ReviewCancers2022

HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment.

Leopoldo Sitia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35626028